Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Guillebaud

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
British Journal of Obstetrics and Gynaecology|September 1, 1978
Longer though lighter menstrual and intermenstural bleeding with copper as compared to inert intrauterine devicesJ Guillebaud, J Bonnar
Contraception|December 1, 1984
Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organismsK Mao, J Guillebaud
Lancet (London, England)|October 30, 1999
Venous thromboembolism and oral contraceptivesR D'Souza, J Guillebaud
British Medical Bulletin|January 1, 1993
Combined oral contraceptives: acceptability and effective useA Kubba, J Guillebaud
British Journal of Obstetrics and Gynaecology|March 1, 1997
Gynaecological aspects of the levonorgestrel-releasing intrauterine systemF Sturridge, J Guillebaud
BMJ (Clinical Research Ed.)|January 25, 1992
Medical abortionM Heard, J Guillebaud
BMJ (Clinical Research Ed.)|June 17, 1998
Data support extended use of levonorgestrel intrauterine systemsD Mansour, J Guillebaud
Lancet (London, England)|November 2, 1991
Safety of DMPAA Szareswki, J Guillebaud
The British Journal of Family Planning|February 19, 1999
Lea's Shield contraceptive device: pilot study of its short-term patient acceptability and aspects of useW Bounds, J Guillebaud
Drug Safety|December 1, 1996
A risk-benefit assessment of the levonorgestrel-releasing intrauterine systemF Sturridge, J Guillebaud
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
British Journal of Obstetrics and Gynaecology|September 1, 1978
Longer though lighter menstrual and intermenstural bleeding with copper as compared to inert intrauterine devicesJ Guillebaud, J Bonnar
Contraception|December 1, 1984
Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organismsK Mao, J Guillebaud
Lancet (London, England)|October 30, 1999
Venous thromboembolism and oral contraceptivesR D'Souza, J Guillebaud
British Medical Bulletin|January 1, 1993
Combined oral contraceptives: acceptability and effective useA Kubba, J Guillebaud
British Journal of Obstetrics and Gynaecology|March 1, 1997
Gynaecological aspects of the levonorgestrel-releasing intrauterine systemF Sturridge, J Guillebaud
BMJ (Clinical Research Ed.)|January 25, 1992
Medical abortionM Heard, J Guillebaud
BMJ (Clinical Research Ed.)|June 17, 1998
Data support extended use of levonorgestrel intrauterine systemsD Mansour, J Guillebaud
Lancet (London, England)|November 2, 1991
Safety of DMPAA Szareswki, J Guillebaud
The British Journal of Family Planning|February 19, 1999
Lea's Shield contraceptive device: pilot study of its short-term patient acceptability and aspects of useW Bounds, J Guillebaud
Drug Safety|December 1, 1996
A risk-benefit assessment of the levonorgestrel-releasing intrauterine systemF Sturridge, J Guillebaud
Pageof 13